Both in Biotechnology
Vaxcyte vs ImmunityBio
Over the past year PCVX returned +63.6% and IBRX returned +243.6%; their daily moves had a correlation of 0.27.
PCVX +63.6% IBRX +243.6%Growth of $1, one year, split-adjusted
| Metric | PCVX | IBRX |
|---|---|---|
| Price | $56.69 | $8.83 |
| Market cap | $8.44B | $9.36B |
| Today | −2.71% | +3.64% |
| 1 month | −5.3% | +9.7% |
| 6 months | +3.1% | +32.6% |
| Year to date | +22.9% | +346.0% |
| 1 year | +66.8% | +247.6% |
| Revenue growth (YoY) | — | +93.9% |
| Gross margin | — | 99.4% |
| Net margin | — | −449.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 56.4× |
| Net cash | $1.49B | -$57.7M |
| Dividend yield | — | — |
| Volatility (60d) | 38.6% | 60.5% |
| Short % of float | 12.7% | 31.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).